Immunocore Commercial LLC
Radnor, PA
- UEI
- FZLMFD51RYN1
- CAGE
- 9EVU6
- Primary NAICS
- 325411 Medicinal and Botanical Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 100 Matsonford Rd Ste 100, Radnor, PA 19087, USA
- Website
- immunocore.com
- Founded
- 2008
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$888 |
| FY2025 | $512,763 |
| FY2024 | $144,478 |
Contract vehicles
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Kimmtrak | Veterans Integrated Service Network 8 (VHA) | $44,179 | |
| Kimmtrack 100 MCG/0.5 ML vial injection | Veterans Integrated Service Network 9 (VHA) | $29,453 | |
| Kimmtrak tabetafusp | Veterans Integrated Service Network 21 (VHA) | $88,358 | |
| Kimmtrak | Veterans Integrated Service Network 9 (VHA) | $44,179 | |
| Emergency kimmtrak | Veterans Integrated Service Network 9 (VHA) | $14,726 |
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | Florham Park, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Incyte Corporation | Wilmington, DE | 325412 Pharmaceutical Preparation Manufacturing |
| Ascendis Pharma, Inc. | — | 325412 Pharmaceutical Preparation Manufacturing |
| Mallinckrodt ARD LLC | Hazelwood, MO | 325412 Pharmaceutical Preparation Manufacturing |
| ADC Therapeutics America, Inc. | New Providence, NJ | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Immunocore Commercial LLC is a foreign-owned, for-profit manufacturer of pharmaceutical goods registered in the System for Award Management (SAM.gov). The company specializes in producing and supplying specialized pharmaceutical products, with a primary focus on KIMMTRAK (tebentafusp-tebn), a 100MCG/0.5ML injectable pharmaceutical product used in hematology-related treatments. While detailed background information beyond its federal contracting activities is not provided in the source documents, the company appears to be a pharmaceutical manufacturer targeting federal healthcare markets, particularly within the Department of Veterans Affairs (VA) healthcare system.
Through its federal contract awards, Immunocore Commercial LLC has consistently provided KIMMTRAK pharmaceutical products to various Veterans Integrated Service Networks (VISNs) across the VA system. The company has been awarded multiple firm fixed-price delivery orders ranging from $14,447.83 to $115,582.64, with most contracts focused on supplying the injectable pharmaceutical product. These contracts have been awarded through both small business set-aside programs and full and open competition, demonstrating the company's flexibility in federal procurement. The majority of these contracts have been non-set-aside awards, though one contract was specifically designated as a Total Small Business set-aside. The primary agency awarding these contracts has been the Department of Veterans Affairs, with deliveries targeted to different regional Veterans Integrated Service Networks, including VISN 9 and VISN 21.
Immunocore Commercial LLC holds two primary Federal Supply Schedule (FSS) Indefinite Delivery Vehicles (IDVs) with the VA. The first is a $225,000 multiple-award FSS contract (36F79724D0026) covering Federal Supply Classification 65 I B, which encompasses drugs, pharmaceuticals, and hematology-related products, with a performance period through November 14, 2028. The second is a previous interim agreement (36F79723D035E) with a $25,000 ceiling value that concluded on November 14, 2023. Most recently, the company was awarded a $4,000,000 single-award Blanket Purchase Agreement (BPA) by the National Acquisition Center, with an ultimate completion date of April 9, 2026. These IDVs have enabled Immunocore Commercial LLC to consistently supply specialized pharmaceutical products, particularly KIMMTRAK, to VA healthcare facilities through firm fixed-price delivery orders across multiple Veterans Integrated Service Networks.
Quick answers
Is Immunocore Commercial LLC registered in SAM.gov?
Yes. Immunocore Commercial LLC's SAM.gov registration is active through September 9, 2027.
What is Immunocore Commercial LLC's CAGE code?
Immunocore Commercial LLC's CAGE code is 9EVU6, and its Unique Entity ID (UEI) is FZLMFD51RYN1.
Which contract vehicles does Immunocore Commercial LLC hold?
Immunocore Commercial LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has Immunocore Commercial LLC received in federal contracts?
Federal contracts obligated $512,763 to Immunocore Commercial LLC in fiscal year 2025 and $656,354 in fiscal years 2023 through 2027.
How does Immunocore Commercial LLC rank among federal contractors?
Immunocore Commercial LLC ranked #91 in NAICS 325412 in FY2025.
What is Immunocore Commercial LLC's most recent federal award?
Immunocore Commercial LLC's most recent federal contract award is Kimmtrak (36C24825N0605), from Veterans Integrated Service Network 8 (VHA), on April 8, 2025.
On GovTribe
See Immunocore Commercial LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors